Components of a complex substance
Pharmacological Group
Latin name
Dioxomethyltetrahydropyrimidinum + Retinolum ( Dioxomethyltetrahydropyrimidini + Retinoli).
Used in the treatment of
- T35 Frostbite involving multiple body regions and unspecified frostbite
- T30 Burn and corrosion, body region unspecified
- R23.4 Changes in skin texture
- L99.8 Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere
- L98.4 Chronic ulcer of skin, not elsewhere classified
- L85.2 Keratosis punctata (palmaris et plantaris)
- L85.0 Acquired Ichthyosis
- L40 Psoriasis
- L30.9 Dermatitis, unspecified
- L21 Seborrhoeic dermatitis
- L20.8 Other atopic dermatitis
- L20 Atopic dermatitis
- L08.0 Pyoderma
- Y42.0 Adverse effects in therapeutic use, glucocorticoids and synthetic analogues
Analogs by action
- 61% Dioxomethyltetrahydropyrimidine+Chloramphenicol [Dioxomethyltetrahydropyrimidine and more 1Chloramphenicol]
- 60% Vitamin E+Retinol [Vitamin E and more 1Retinol]
- 45% Hydroxymethylquinoxalindioxide+Dioxomethyltetrahydropyrimidine+Trimecaine [Hydroxymethylquinoxalindioxide and more 2Dioxomethyltetrahydropyrimidine, Trimecaine]
- 44% Dioxomethyltetrahydropirimidine+Lidocaine+Ofloxacine Dioxomethyltetrahydropyrimidine+Lidocaine+Ofloxacin [Lidocaine and more 2Ofloxacin, Dioxomethyltetrahydropyrimidine]
- Show all
Included in the composition
- 3.1-4.1€ Redecil